Stockscreener 앱 받기
4.26
2.40%
0.10
시간 외 거래:
4.31
0.05
+1.17%
Personalis Inc 주식(PSNL)의 최신 뉴스
Personalis Inc (PSNL) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Personalis Inc (PSNL) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Market Momentum Report: Personalis Inc (PSNL)’s Negative Close at 3.78 - DWinneX
Results from Personalis Inc (PSNL) show potential - uspostnews.com
Examining the Potential Price Growth of Personalis Inc (PSNL) - knoxdaily.com
Personalis (PSNL) Reveals Promising Interim Results in Colorecta - GuruFocus
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study - BioSpace
Personalis' NeXT Personal® Detects 100% of Colorectal Cancer Rel - GuruFocus
Investor’s Delight: Personalis Inc (PSNL) Closes Weak at 4.14, Down -1.90 - DWinneX
Breakthrough: New Cancer Blood Test Detects Colorectal Relapses Months Before Imaging - Stock Titan
Gaining Ground: Personalis Inc (PSNL) Closes Lower at 3.51, Down -3.04 - DWinneX
PSNL Stock Sees Surge of Approximately 12.88% in Last Five Days - knoxdaily.com
Several Personalis Insiders Sell Shares Sending Potential Negative Signal - simplywall.st
Personalis Inc (PSNL) produces promising results - uspostnews.com
Personalis to Announce First Quarter 2025 Financial Results - BioSpace
Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires? - Insider Monkey
10 Best Multibagger Penny Stocks to Buy According to Billionaires - Insider Monkey
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection | PSNL Stock News - GuruFocus
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection - Business Wire
LPL Financial LLC Sells 6,773 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World
Renaissance Technologies LLC Trims Stock Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
PSNL Stock Sees Decline of Approximately -2.66% in Last Five Days - knoxdaily.com
Arrowstreet Capital Limited Partnership Lowers Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Raymond James Financial Inc. Buys New Stake in Personalis, Inc. (NASDAQ:PSNL) - Defense World
American Century Companies Inc. Buys 25,011 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World
Needham & Company LLC Reiterates “Buy” Rating for Personalis (NASDAQ:PSNL) - Defense World
With 33% stake, Personalis, Inc. (NASDAQ:PSNL) seems to have captured institutional investors' interest - Yahoo Finance
What 5 Analyst Ratings Have To Say About Personalis - Benzinga
Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference - BioSpace
Personalis, Inc. (NASDAQ:PSNL) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - Defense World
Personalis Inc’s (PSNL) Stock Is Harder To Predict Than You Think - Stocks Register
What You Can Learn From Personalis, Inc.'s (NASDAQ:PSNL) P/S After Its 40% Share Price Crash - simplywall.st
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Personalis (NASDAQ:PSNL) Now Covered by Craig Hallum - Defense World
Craig-Hallum Initiates Coverage of Personalis (PSNL) with Buy Recommendation - Nasdaq
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Craig Hallum Initiates Coverage on Personalis With Buy Rating, $8 Price Target -March 17, 2025 at 07:58 am EDT - Marketscreener.com
Hold Rating for Personalis: Balancing Strong Enterprise Sales and Future Uncertainties - TipRanks
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL - Benzinga
Personalis stock target cut to $7 by BTIG, maintains Buy rating - Investing.com Canada
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Yahoo Finance
Can This New Blood Test Revolutionize Breast Cancer Monitoring? Detects Recurrence Years Before Imaging - Stock Titan
Personalis’ (PSNL) “Buy” Rating Reiterated at HC Wainwright - Defense World
Needham & Company LLC Cuts Personalis (NASDAQ:PSNL) Price Target to $7.00 - Defense World
Personalis, Inc. (NASDAQ:PSNL) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St
Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC - MarketBeat
Personalis Full Year 2024 Earnings: Beats Expectations - Yahoo
Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results - MarketBeat
Personalis stock target cut to $7.00 at Needham, retains buy rating By Investing.com - Investing.com South Africa
Personalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
0.34%
0.46%
자본화:
|
볼륨(24시간):